Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-24325.8China
EG.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16962.5China
EG.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JC.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCFEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CH.1.1.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CH.1.1.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CH.1.1.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CH.1.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.109EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.109EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.109ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.109ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.109EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.109EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.109ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.109ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FR.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FR.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FR.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FR.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FR.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used